- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03293979
Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis
August 8, 2018 updated by: Groupe Hospitalier Paris Saint Joseph
It appears that the heavyness of flu pathology, the diagnosis limits and the validity of it was well studied in the last years.However, the economical impact and the organisation benefit in emergency service is not yet evaluated Our purpose is to study the impact of implementation of fast flu diagnosis by molecular biology available in emergency service in the economic field .
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
301
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ile-de-France
-
Paris, Ile-de-France, France, 75014
- Groupe hospitalier Paris saint Joseph
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
each patient admitted in emergy service between february 2016 and april 2016
Description
Inclusion Criteria:
- respiratory symptoms
- fever >38°C
- general symptoms of flu like pathology
Exclusion Criteria:
- cognitive disorders
- patient with guardianship
- patient already having a flu diagnosis in the last 7 days
- without social protection.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
time to have the result of the biological test
Time Frame: 3 hours
|
3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: GANANSIA Olivier, MD, GHPSJ
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 22, 2016
Primary Completion (Actual)
December 31, 2016
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
September 21, 2017
First Submitted That Met QC Criteria
September 21, 2017
First Posted (Actual)
September 26, 2017
Study Record Updates
Last Update Posted (Actual)
August 9, 2018
Last Update Submitted That Met QC Criteria
August 8, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TestAiFluA&B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Flu
-
Aarogyam UKCompletedFlu Like Symptom | Flu Like IllnessUnited Kingdom
-
University of PennsylvaniaNational Institute on Aging (NIA); University of WashingtonActive, not recruitingFlu | Behavior, Health | Flu VaccinationUnited States
-
Kemin Foods LCKGK Science Inc.CompletedStress | Flu | Cold | Flu Symptom | Cold Symptom | Gastrointestinal Tolerance | SupplementCanada
-
Folia Biotech Inc.Unknown
-
Franklin Health ResearchArtemis International; IPRONARecruitingCOVID-19 | Flu | Cold | Upper Respiratory Tract Infection | Flu Like IllnessUnited States
-
Mahidol UniversityCompleted
-
M.D. Anderson Cancer CenterRecruiting
-
Vanderbilt University Medical CenterCompleted
-
David H. CanadayNational Institute of Allergy and Infectious Diseases (NIAID); Brown University and other collaboratorsCompleted
-
Centre Hospitalier Universitaire de NiceCentre Hospitalier Princesse GraceUnknown
Clinical Trials on Test A i Flu A&B implemented in emergency service
-
EDAN Instruments Inc.MDx CRO (MED IVD HEALTHTECH S.L.)RecruitingSARS-CoV2 Infection | Influenza A | Respiratory Syncytial Virus (RSV) | Influenza BSpain
-
Ellume Pty LtdCompleted
-
Medical Group Care, LLCCSSi Life SciencesCompletedCOVID-19 | Influenza A | Influenza BUnited States
-
Ellume Pty LtdCompleted
-
LumiraDx UK LimitedCompletedCOVID-19 | Influenza A | RSV Infection | Influenza Type BUnited States
-
Abbott Rapid DxCompletedCOVID-19 | Influenza A | Influenza Type BUnited States
-
Ellume Pty LtdCompletedInfluenza A | Influenza BAustralia
-
The Institute of Molecular and Translational Medicine...University Hospital Olomouc; Cancer Research Czech RepublicRecruitingCervical Cancer | Oropharyngeal Cancer | Human Papillomavirus Infection | Cervical DysplasiaCzechia
-
Mansoura UniversityCompleted
-
University Hospital, Strasbourg, FranceCompletedEndodontic Inflammation | Pulpitides | Toothaches | Operative DentistryFrance